Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL906580 | 0.83 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL29579616 | 0.83 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL2482179 | 0.81 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL6639407 | 0.78 | GCGR (0.30) | KCNH2 | |
| SCHEMBL153619 | 0.76 | PDE10A (0.35) | KCNH2 | |
| SCHEMBL29779695 | 0.76 | PDE10A (0.35) | KCNH2 | |
| SCHEMBL3748371 | 0.75 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL29865866 | 0.74 | CCR1 (0.39) | RAB9AKMT2AKCNH2L3MBTL1POLB | |
| SCHEMBL246415 | 0.74 | CCR1 (0.39) | RAB9AKMT2AKCNH2L3MBTL1POLB | |
| SCHEMBL23782512 | 0.74 | CYP1A2 (0.44) | RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187690-B2 | Rare earth metal complex having phenanthroline compound as ligand | B.R.A.H.M.S. GMBH (DE) | 2015-11-17 | — | — | US | disclosed |
| EP-2683725-B1 | RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND | BRAHMS GMBH (DE) | 2015-08-26 | — | — | EP | disclosed |
| EP-2477986-B1 | PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS | BRAHMS GMBH (DE) | 2014-11-12 | — | — | EP | disclosed |
| US-20140058073-A1 | RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND | B.R.A.H.M.S. GMBH (DE) | 2014-02-27 | — | — | US | disclosed |
| US-8648194-B2 | Compounds having phenanthroline structure | B.R.A.H.M.S GMBH (DE) | 2014-02-11 | — | — | US | disclosed |
| EP-2683725-A1 | RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND | B.R.A.H.M.S GmbH (DE) | 2014-01-15 | — | — | EP | disclosed |
| US-20120238748-A1 | NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE | B.R.A.H.M.S GMBH (DE) | 2012-09-20 | — | — | US | disclosed |
| WO-2012124310-A1 | RARE EARTH METAL COMPLEX HAVING PHENANTHROLINE COMPOUND AS LIGAND | B.R.A.H.M.S GMBH (DE) | 2012-09-20 | — | — | WO | disclosed |
| EP-2477986-A1 | PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS | B.R.A.H.M.S GmbH (DE) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011030566-A1 | PHENANTHROLINE DERIVATIVES AND THEIR USE AS LIGANDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238748-A1 | NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE | PAH, BPTF, HDAC1 | RAB9A 1777/4885KMT2A 506/4885KCNH2 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.